Ulland Investment Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$140K Hold
360
0.1% 88
2026
Q1
$170K Hold
360
0.15% 74
2025
Q4
$168K Hold
360
0.13% 73
2025
Q3
$153K Hold
360
0.12% 71
2025
Q2
$138K Hold
360
0.11% 77
2025
Q1
$124K Hold
360
0.1% 74
2024
Q4
$108K Hold
360
0.07% 76
2024
Q3
$146K Hold
360
0.11% 68
2024
Q2
$116K Sell
360
-80
-18% -$26K 0.08% 79
2024
Q1
$147K Sell
440
-27
-6% -$8.25K 0.12% 69
2023
Q4
$126K Hold
467
0.13% 69
2023
Q3
$115K Hold
467
0.13% 70
2023
Q2
$142K Hold
467
0.15% 58
2023
Q1
$123K Hold
467
0.14% 62
2022
Q4
$112K Hold
467
0.13% 66
2022
Q3
$86K Hold
467
0.09% 69
2022
Q2
$78K Hold
467
0.08% 77
2022
Q1
$117K Buy
467
+70
+18% +$17.6K 0.09% 72
2021
Q4
$102K Buy
+397
New +$97.1K 0.07% 79

Other funds holding HCA

Ulland Investment Advisors's HCA Position: Q2 2026 in Review

Ulland Investment Advisors held its HCA Healthcare (HCA) position steady in Q2 2026 at 360 shares worth $140K. The position accounts for 0.1% of the portfolio, ranked #88.

Ulland Investment Advisors first reported a position in HCA in Q4 2021 and has held it in 19 quarters since. The position peaked at $170K in Q1 2026. 698 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Ulland Investment Advisors held 360 shares of HCA Healthcare worth $140K as of Q2 2026.
  • Ulland Investment Advisors left its HCA Healthcare share count unchanged in Q2 2026.
  • HCA Healthcare made up 0.1% of Ulland Investment Advisors's portfolio in Q2 2026, its #88 holding.
  • Ulland Investment Advisors first reported a position in HCA Healthcare in Q4 2021 and has held it in 19 quarters since.
  • Ulland Investment Advisors's HCA Healthcare position peaked at $170K in Q1 2026.
  • 698 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Ulland Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.